Study suggests initiating saquinavir in early disease may increase duration of response.
D018791:CD4 Lymphocyte Count / Q000187:drug effects; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D012367:RNA, Viral / Q000187:drug effects*; D019258:Saquinavir / Q000008:administration & dosage*; D013997:Time Factors; D016896:Treatment Outcome
D017320:HIV Protease Inhibitors; D012367:RNA, Viral; D019258:Saquinavir